Showing results (1-10 of 447) with videos related to
Sort By:
Pageof 45
Expert Review of Anticancer Therapy|April 21, 2009
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumabRichard S Finn, Andrew X ZhuHepatology (Baltimore, Md.)|May 8, 2020
Evolution of Systemic Therapy for Hepatocellular CarcinomaRichard S Finn, Andrew X ZhuHepatology (Baltimore, Md.)|September 8, 2017
Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysisRichard S Finn, Andrew X Zhu, Wigdan Farah, et al.Seminars in Liver Disease|March 5, 2013
Emerging targeted strategies in advanced hepatocellular carcinomaRichard S FinnClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?Richard S FinnLiver Cancer|October 26, 2013
Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR InhibitionRichard S FinnNature Reviews. Clinical Oncology|November 12, 2021
Immunotherapies for hepatocellular carcinomaJosep M Llovet, Florian Castet, Mathias Heikenwalder, et al.Cancer|November 28, 2007
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinomaAndrew X ZhuBMC Medicine|August 26, 2009
Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?Andrew X ZhuChinese Clinical Oncology|April 6, 2015
Current status of hepatocellular carcinoma in the United StatesAndrew X ZhuPageof 45